Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Pharma Mar Cash from Operations (Annual) : 59.96M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 59.96M |
| December 31, 2024 | 6.519M |
| December 31, 2023 | -14.54M |
| December 31, 2022 | 40.27M |
| December 31, 2021 | 30.35M |
| December 31, 2020 | 317.99M |
| December 31, 2019 | -29.25M |
| December 31, 2018 | -19.85M |
| December 31, 2017 | -1.646M |
| December 31, 2016 | -9.308M |
| December 31, 2015 | 12.31M |
| Date | Value |
|---|---|
| December 31, 2014 | 29.33M |
| December 31, 2013 | 21.70M |
| December 31, 2012 | 8.117M |
| December 31, 2011 | -5.955M |
| December 31, 2010 | -28.98M |
| December 31, 2009 | -31.52M |
| December 31, 2008 | -52.17M |
| December 31, 2007 | -67.29M |
| December 31, 2006 | -70.43M |
| December 31, 2005 | -41.03M |
| December 31, 2004 | -26.71M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Oryzon Genomics SA | -2.659M |
| Grifols SA | 1.182B |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alkermes Plc | 520.75M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |